Filtered By:
Condition: Alzheimer's

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 33 results found since Jan 2013.

Brain Imaging and Behavior, Vol. 6, Issue 4 - New Issue Alert
Monday, December 31 Dear Valued Customer, We are pleased to deliver your requested table of contents alert for Brain Imaging and Behavior. Volume 6 Number 4 is now available on SpringerLink. Register for Springer's email services providing you with info on the latest books in your field. ... More! In this issue: ADNI: Friday Harbor 2011 Workshop SPECIAL ISSUE Advanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference Dan Mungas, Paul K. Crane, Laura E. Gibbons, Jennifer&n...
Source: Intelligent Insights on Intelligence Theories and Tests (aka IQ's Corner) - December 31, 2012 Category: Neurologists Source Type: blogs

FAU Named a ‘Research Center of Excellence’ for Lewy Body Dementia
The Lewy Body Dementia Association (LBDA) named Florida Atlantic University as a LBDA Research Center of Excellence (RCOE).ByAlzheimer's Reading RoomThe LBDA is the leading advocacy group dedicated to raising awareness and advancing research about Lewy Body Dementia (LBD)LBD affects 1.4 million Americans and their families, making it one of the most common forms of dementia.What is the Difference Between Alzheimer ’s and DementiaThe centers are selected for their clinical expertise in LBD, experience running clinical trials, capacity of facilities and geographic location (combined, the 33 principal investigators have run...
Source: Alzheimer's Reading Room, The - April 4, 2018 Category: Neurology Tags: dementia dementia test fau james galvin LBD LBDA Lewy Body Dementia lewy body dementia test Source Type: blogs

"Skinny Fat" in Older Adults May Predict Dementia, Alzheimer ’s Risk
This study was supported by grants from the National Institute on Aging of the National Institutes of Health (R01 AG040211 and P30 AG008051), the Morris and Alma Schapiro Fund and the New York State Department of Health.About the Charles E. Schmidt College of Medicine:FAU ’s Charles E. Schmidt College of Medicine is one of approximately 151 accredited medical schools in the U.S.About Florida Atlantic University:Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University, with an annual economic impact of $6.3 billion, serves more t...
Source: Alzheimer's Reading Room, The - July 8, 2018 Category: Neurology Tags: alzheimers alzheimers research Cognition cognitive performance dementia fat science skinny fat various cognition tests Source Type: blogs

Alzheimer's Care Resource Centers are a Useful Tool for Alzheimer's Caregivers
The Alzheimer's Disease Research Centers around the country are an important source of information and help for Alzheimer's caregivers and family caregivers.Alzheimer's Reading RoomI often receive emails from readers asking me how to find someone that is experienced in the diagnosis of dementia, or searching for help on other Alzheimer's care related problems. When this happens, the first thing I do is ask them their location.Alzheimer's CareThere are about 30 Alzheimer's Disease Research Centers (ADRC) around the country. When most people think ADRC they think research.However, most ADRCs have doctors in practice, practic...
Source: Alzheimer's Reading Room, The - August 6, 2016 Category: Neurology Tags: ADRC alzheimer's care Alzheimer's Disease Research Centers family caregiving help alzheimer's help with dementia help with dementia care memory care Source Type: blogs

History and Overview of Digital Pathology Webinar Scheduled for Monday, March 8
I recently received notification fromMargaret E. Flanagan, M.D., assistant professor of pathology at Northwestern, about an upcoming event featuring several well-known neuropathologists.  You can register for the eventhere. Thanks very much, Dr. Flanagan!Dr. Margaret E. Flanagan History& Overview of Digital PathologyWebinar - March 8, 2021  The ADRC Digital Pathology Working Group and National Alzheimer ' s Coordinating Center are excited to host the following webinar on Monday, March 8, 2021 at 11am ET/ 8am PT! History and Overview of Digital PathologyJoin us on March 8th as ...
Source: neuropathology blog - February 26, 2021 Category: Radiology Source Type: blogs

Alzheimer’s and Skin Cancer
People who have non-melanoma skin cancer may be less likely to develop Alzheimer's Disease. +Alzheimer's Reading Room People who have non-melanoma skin cancer may be less likely to develop Alzheimer's disease, according to research carried out by scientists at Albert Einstein College of Medicine of Yeshiva University. The findings were published in the May 15, 2013 online issue of Neurology, the journal of the American Academy of Neurology. "Several previous studies had found correlations between cancer and the risk for developing Alzheimer's disease," said lead author Robert White, an Einstein medical student enrolled...
Source: Alzheimer's Reading Room, The - May 17, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

Sleep Deprivation May Contribute to Alzheimer’s
A study published in JAMA Neurology reports that participants with evidence of preclinical Alzheimer's experienced worse sleep efficiency than those with no evidence of potential Alzheimer’s. One hundred forty five people between ages 45 and 75 took part in the study conducted by researchers at the Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine.   While none of the study...
Source: Carol Bradley Bursack's SharePosts - June 6, 2013 Category: Dementia Authors: Carol Bradley Bursack Source Type: blogs

ProPublica Publishes Medicare Part D Prescriber Data
In 2010, the "investigative journalist organization" known as ProPubilca, through donations from the Pew Foundation and several other organizations geared towards attacking industry, began the "Dollars for Docs" campaign. As we have covered extensively since the launch of that campaign, ProPublica aggregated the payment reporting data of approximately 15 manufacturers who were reporting their payments publicly—either as a requirement of a corporate integrity agreement (CIA) with HHS-OIG, or voluntarily—and then created a searchable, aggregated website. Additionally, ProPublica teamed up with national and local medi...
Source: Policy and Medicine - June 13, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs

Those with Type 2 Diabetes Have a 50% Greater Risk of Dementia
Conclusion In diabetic patients those initiating metformin had a five year reduced risk of dementia in comparison to patients initiating other therapies. Animal models suggest metformin may contribute to neurogenesis and trials are evaluating metformin as a potential therapeutic for mild cognitive impairment. These results are preliminary evidence that benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health. Related Content What is the Difference Between Alzheimer’s and Dementia Test Your Memory for Alzheimer's (5 Best Tests) How to Reduce Memory Loss Is Alzheimer's World an Irrati...
Source: Alzheimer's Reading Room, The - July 15, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

John Hopkins - Blood Pressure Drugs Decrease Risk of Dementia Alzheimer's
A Johns Hopkins led analysis of data gathered on more than 3,000 elderly Americans strongly suggests that taking specific medications to control blood pressure may reduce the risk of dementia due to Alzheimer's disease (AD). +Alzheimer's Reading Room The Gist In a report published in a recent edition of the journal Neurology, a team of researchers found that people over the age of 75 with normal cognition who used diuretics, angiotensin-1 receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors showed a reduced risk of AD dementia by at least 50 percent. In addition, diuretics were associated ...
Source: Alzheimer's Reading Room, The - October 17, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

A Good Night's Rest May Literally Clear the Mind
In this study, Dr. Nedergaard and her colleagues unexpectedly found that sleep may be also be the period when the brain cleanses itself of toxic molecules. The Alzheimer's Reading Room Knowledge Base  contains more than 4,000 articles. Their results, published in Science, show that during sleep a plumbing system called the glymphatic system may open, letting fluid flow rapidly through the brain. Dr. Nedergaard's lab recently discovered the glymphatic system helps control the flow of cerebrospinal fluid (CSF), a clear liquid surrounding the brain and spinal cord. "It's as if Dr. Nedergaard and her colleagues have...
Source: I am an Alzheimer's Caregiver - October 17, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

Merry Christmas
“Christmas is doing a little something extra for someone.” ― Charles M. Schulz+Bob DeMarco +Dementia Reading Room +AlzheimersReadingRoom To learn more about Alzheimer's and Dementia care visit the Alzheimer's Reading Room
Source: I am an Alzheimer's Caregiver - December 25, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs

Enabling partnerships for Alzheimer's disease drug development—meeting report
It was the best of times, it was the worst of times... --Charles Dickens. These words sum up the state of Alzheimer’s disease (AD) research, specifically therapy development, over the last few years. On the one hand, the budget climate and dismal therapeutic results cloud the future. On the other hand, there are tremendous opportunities presented by the U.S. National Plan to Address Alzheimer’s Disease and by the emergence of systems and precision medicine. These could transform AD research and drug development.
Source: Inside NIA: A Blog for Researchers - June 12, 2013 Category: Geriatrics Authors: Suzana Petanceska, Program Director, Division of Neuroscience Source Type: blogs

Senate Finance Committee Releases Results of Investigation Into Gilead’s Pricing Strategy for Hepatitis-C Drugs
Discussion The Gilead example does not represent the life science community well, and highlights the need to put extra thought into the way drugs are priced. Gilead clearly was allowing marketing to drive the pricing ship and displayed what could be considered an almost reckless disregard for availability and affordability. Pharmaceutical companies can, and should, attempt to maximize their profit, but should consider doing so in a way that ensures availability and affordability for patients and payers alike. While there is no clear answer to the drug pricing dilemma we currently face, perhaps more thought and research s...
Source: Policy and Medicine - December 2, 2015 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs